Chemicals - Specialty
Build Your Comparison
Side-by-side financial analysisStock Comparison
NGVT vs KWR vs KO vs CBT vs FUL
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Beverages - Non-Alcoholic
Chemicals - Specialty
Chemicals - Specialty
NGVT vs KWR vs KO vs CBT vs FUL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals - Specialty | Beverages - Non-Alcoholic | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $2.54B | $2.50B | $355.61B | $4.58B | $3.45B |
| Revenue (TTM) | $1.21B | $1.93B | $49.28B | $3.58B | $3.47B |
| Net Income (TTM) | $-128M | $4M | $13.70B | $285M | $152M |
| Gross Margin | 39.3% | 34.4% | 61.7% | 24.8% | 31.5% |
| Operating Margin | 22.8% | 3.7% | 29.3% | 15.7% | 10.9% |
| Forward P/E | 14.6x | 20.6x | 25.3x | 13.9x | 13.5x |
| Total Debt | $1.24B | $929M | $45.49B | $1.22B | $2.02B |
| Cash & Equiv. | $78M | $180M | $10.27B | $258M | $107M |
NGVT vs KWR vs KO vs CBT vs FUL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Ingevity Corporation (NGVT) | 100 | 136.9 | +36.9% |
| Quaker Chemical Cor… (KWR) | 100 | 77.8 | -22.2% |
| The Coca-Cola Compa… (KO) | 100 | 184.9 | +84.9% |
| Cabot Corporation (CBT) | 100 | 236.6 | +136.6% |
| H.B. Fuller Company (FUL) | 100 | 142.7 | +42.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NGVT vs KWR vs KO vs CBT vs FUL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NGVT is the #2 pick in this set and the best alternative if momentum is your priority.
- +66.6% vs FUL's +15.2%
KWR ranks third and is worth considering specifically for growth.
- 2.7% revenue growth vs NGVT's -17.0%
KO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 56 yrs, beta -0.20, yield 2.5%
- Rev growth 1.9%, EPS growth 23.6%, 3Y rev CAGR 3.7%
- 121.1% 10Y total return vs CBT's 119.6%
- PEG 2.26 vs FUL's 4.34
CBT is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.82, Low D/E 71.3%, current ratio 1.61x
- Beta 0.82, yield 2.0%, current ratio 1.61x
- Beta 0.82 vs KWR's 1.36
Among these 5 stocks, FUL doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.7% revenue growth vs NGVT's -17.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 27.8% margin vs NGVT's -10.6% | |
| Stability / Safety | Beta 0.82 vs KWR's 1.36 | |
| Dividends | 2.5% yield, 56-year raise streak, vs FUL's 1.4%, (1 stock pays no dividend) | |
| Momentum (1Y) | +66.6% vs FUL's +15.2% | |
| Efficiency (ROA) | 13.1% ROA vs NGVT's -7.3%, ROIC 15.8% vs 14.2% |
NGVT vs KWR vs KO vs CBT vs FUL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
NGVT vs KWR vs KO vs CBT vs FUL — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 4 of 6 categories
FUL leads 1 • NGVT leads 0 • KWR leads 0 • CBT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KO is the larger business by revenue, generating $49.3B annually — 40.7x NGVT's $1.2B. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to NGVT's -10.6%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.2B | $1.9B | $49.3B | $3.6B | $3.5B |
| EBITDAEarnings before interest/tax | $378M | $143M | $15.5B | $731M | $472M |
| Net IncomeAfter-tax profit | -$128M | $4M | $13.7B | $285M | $152M |
| Free Cash FlowCash after capex | $246M | $143M | $12.6B | $459M | $121M |
| Gross MarginGross profit ÷ Revenue | +39.3% | +34.4% | +61.7% | +24.8% | +31.5% |
| Operating MarginEBIT ÷ Revenue | +22.8% | +3.7% | +29.3% | +15.7% | +10.9% |
| Net MarginNet income ÷ Revenue | -10.6% | +0.2% | +27.8% | +8.0% | +4.4% |
| FCF MarginFCF ÷ Revenue | +20.3% | +7.4% | +25.5% | +12.8% | +3.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.2% | +8.5% | +12.1% | -3.4% | -3.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +196.4% | +54.8% | +18.2% | -23.1% | +122.2% |
Valuation Metrics
FUL leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 14.6x trailing earnings, CBT trades at a 46% valuation discount to KO's 27.2x P/E. Adjusting for growth (PEG ratio), KO offers better value at 2.43x vs FUL's 7.45x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.5B | $2.5B | $355.6B | $4.6B | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $3.7B | $3.3B | $390.8B | $5.5B | $5.4B |
| Trailing P/EPrice ÷ TTM EPS | -15.61x | -1031.86x | 27.18x | 14.56x | 23.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.60x | 20.59x | 25.27x | 13.88x | 13.48x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.43x | — | 7.45x |
| EV / EBITDAEnterprise value multiple | 10.05x | 12.03x | 26.39x | 7.14x | 9.28x |
| Price / SalesMarket cap ÷ Revenue | 2.17x | 1.33x | 7.42x | 1.23x | 0.99x |
| Price / BookPrice ÷ Book value/share | 87.73x | 1.83x | 10.40x | 2.79x | 1.76x |
| Price / FCFMarket cap ÷ FCF | 9.27x | 31.07x | 67.15x | 11.71x | 28.44x |
Profitability & Efficiency
Evenly matched — KWR and KO and CBT each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-156 for NGVT. KWR carries lower financial leverage with a 0.67x debt-to-equity ratio, signaling a more conservative balance sheet compared to NGVT's 41.84x. On the Piotroski fundamental quality scale (0–9), KO scores 7/9 vs KWR's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -156.1% | +0.3% | +41.1% | +16.8% | +7.6% |
| ROA (TTM)Return on assets | -7.3% | +0.2% | +13.1% | +7.4% | +2.9% |
| ROICReturn on invested capital | +14.2% | +6.6% | +15.8% | +17.4% | +7.8% |
| ROCEReturn on capital employed | +17.1% | +7.6% | +17.3% | +21.3% | +9.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 7 | 6 | 7 |
| Debt / EquityFinancial leverage | 41.84x | 0.67x | 1.33x | 0.71x | 1.01x |
| Net DebtTotal debt minus cash | $1.2B | $749M | $35.2B | $957M | $1.9B |
| Cash & Equiv.Liquid assets | $78M | $180M | $10.3B | $258M | $107M |
| Total DebtShort + long-term debt | $1.2B | $929M | $45.5B | $1.2B | $2.0B |
| Interest CoverageEBIT ÷ Interest expense | -0.86x | 1.41x | 10.70x | 14.72x | 2.62x |
Total Returns (Dividends Reinvested)
KO leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KO five years ago would be worth $16,560 today (with dividends reinvested), compared to $6,392 for KWR. Over the past 12 months, NGVT leads with a +66.6% total return vs FUL's +15.2%. The 3-year compound annual growth rate (CAGR) favors KO at 13.7% vs KWR's -9.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +19.8% | +4.7% | +20.3% | +32.1% | +6.2% |
| 1-Year ReturnPast 12 months | +66.6% | +22.7% | +17.2% | +17.4% | +15.2% |
| 3-Year ReturnCumulative with dividends | +33.4% | -25.1% | +47.0% | +26.6% | +1.5% |
| 5-Year ReturnCumulative with dividends | -10.8% | -36.1% | +65.6% | +55.8% | -0.1% |
| 10-Year ReturnCumulative with dividends | +111.0% | +77.9% | +121.1% | +119.6% | +50.6% |
| CAGR (3Y)Annualised 3-year return | +10.1% | -9.2% | +13.7% | +8.2% | +0.5% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than KWR's 1.36 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 98.3% from its 52-week high vs KWR's 78.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.27x | 1.36x | -0.20x | 0.82x | 1.18x |
| 52-Week HighHighest price in past year | $79.05 | $183.00 | $84.04 | $89.46 | $68.63 |
| 52-Week LowLowest price in past year | $39.74 | $111.32 | $65.35 | $58.33 | $48.71 |
| % of 52W HighCurrent price vs 52-week peak | +91.1% | +78.9% | +98.3% | +98.0% | +92.7% |
| RSI (14)Momentum oscillator 0–100 | 55.7 | 53.5 | 60.6 | 57.0 | 58.2 |
| Avg Volume (50D)Average daily shares traded | 211K | 151K | 12.7M | 382K | 483K |
Analyst Outlook
KO leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NGVT as "Buy", KWR as "Buy", KO as "Buy", CBT as "Buy", FUL as "Buy". Consensus price targets imply 22.4% upside for KWR (target: $177) vs -1.9% for CBT (target: $86). For income investors, KO offers the higher dividend yield at 2.46% vs KWR's 1.36%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $76.67 | $176.75 | $86.13 | $86.00 | $68.25 |
| # AnalystsCovering analysts | 13 | 14 | 48 | 15 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | +1.4% | +2.5% | +2.0% | +1.4% |
| Dividend StreakConsecutive years of raises | — | 18 | 56 | 14 | 38 |
| Dividend / ShareAnnual DPS | — | $1.97 | $2.04 | $1.77 | $0.91 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.2% | +1.7% | +0.2% | +3.7% | +1.8% |
KO leads in 4 of 6 categories (Income & Cash Flow, Total Returns). FUL leads in 1 (Valuation Metrics). 1 tied.
NGVT vs KWR vs KO vs CBT vs FUL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NGVT or KWR or KO or CBT or FUL a better buy right now?
For growth investors, Quaker Chemical Corporation (KWR) is the stronger pick with 2.
7% revenue growth year-over-year, versus -17. 0% for Ingevity Corporation (NGVT). Cabot Corporation (CBT) offers the better valuation at 14. 6x trailing P/E (13. 9x forward), making it the more compelling value choice. Analysts rate Ingevity Corporation (NGVT) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NGVT or KWR or KO or CBT or FUL?
On trailing P/E, Cabot Corporation (CBT) is the cheapest at 14.
6x versus The Coca-Cola Company at 27. 2x. On forward P/E, H. B. Fuller Company is actually cheaper at 13. 5x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Coca-Cola Company wins at 2. 26x versus H. B. Fuller Company's 4. 34x.
03Which is the better long-term investment — NGVT or KWR or KO or CBT or FUL?
Over the past 5 years, The Coca-Cola Company (KO) delivered a total return of +65.
6%, compared to -36. 1% for Quaker Chemical Corporation (KWR). Over 10 years, the gap is even starker: KO returned +121. 1% versus FUL's +50. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NGVT or KWR or KO or CBT or FUL?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
20β versus Quaker Chemical Corporation's 1. 36β — meaning KWR is approximately -781% more volatile than KO relative to the S&P 500. On balance sheet safety, Quaker Chemical Corporation (KWR) carries a lower debt/equity ratio of 67% versus 42% for Ingevity Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — NGVT or KWR or KO or CBT or FUL?
By revenue growth (latest reported year), Quaker Chemical Corporation (KWR) is pulling ahead at 2.
7% versus -17. 0% for Ingevity Corporation (NGVT). On earnings-per-share growth, the picture is similar: Ingevity Corporation grew EPS 61. 1% year-over-year, compared to -102. 2% for Quaker Chemical Corporation. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NGVT or KWR or KO or CBT or FUL?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus -14. 3% for Ingevity Corporation — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus 9. 4% for KWR. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NGVT or KWR or KO or CBT or FUL more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, The Coca-Cola Company (KO) is the more undervalued stock at a PEG of 2. 26x versus H. B. Fuller Company's 4. 34x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, H. B. Fuller Company (FUL) trades at 13. 5x forward P/E versus 25. 3x for The Coca-Cola Company — 11. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KWR: 22. 4% to $176. 75.
08Which pays a better dividend — NGVT or KWR or KO or CBT or FUL?
In this comparison, KO (2.
5% yield), CBT (2. 0% yield), FUL (1. 4% yield), KWR (1. 4% yield) pay a dividend. NGVT does not pay a meaningful dividend and should not be held primarily for income.
09Is NGVT or KWR or KO or CBT or FUL better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 5% yield, +121. 1% 10Y return). Both have compounded well over 10 years (KO: +121. 1%, NGVT: +111. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NGVT and KWR and KO and CBT and FUL?
These companies operate in different sectors (NGVT (Basic Materials) and KWR (Basic Materials) and KO (Consumer Defensive) and CBT (Basic Materials) and FUL (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NGVT is a small-cap quality compounder stock; KWR is a small-cap quality compounder stock; KO is a large-cap quality compounder stock; CBT is a small-cap deep-value stock; FUL is a small-cap quality compounder stock. KWR, KO, CBT, FUL pay a dividend while NGVT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.